Glucagon-like Peptide-1 Receptor Agonist Treatment in Type 1 Diabetes: A Review of Current Evidence and Rationale for Use. Can Diabetes Endocrinol Today [Internet]. 12 oct. 2023 [cité 29 mars 2026];1(3):21–26. Disponible à: https://CanadianDiabetesAndEndocrinologyToday.com/article/view/1-3-tsoukas